MedPath

Advancing Care of Primary Aldosteronism in Japan Study

Not Applicable
Recruiting
Conditions
primary aldosteronsim:PA essential hypertension:EHT
Registration Number
JPRN-UMIN000046631
Lead Sponsor
St. Marianna University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
5000
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who were judged not eligible for the study by respective attending physician

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) baseline information,biochemical data, results of confirmatory tests, imaging findings and post-treatment outcomes 2) protocol,decision criteria of AVS 3) treatments and outcomes 4) cost effectiveness
Secondary Outcome Measures
NameTimeMethod
1)Pathological findings 2)Markers of target organ damage:Kidney(eGFR,BUN,Cr),Heart(ECG,CTR) 3)Clinical course(6M,1Y,3Y,5Y):base line informations, Laboratory data 4)Immunohistochemical staining
© Copyright 2025. All Rights Reserved by MedPath